Option Care Health Inc. (BIOS)

3.25
0.15 5.00
NASDAQ : Health Services
Prev Close 3.10
Open 3.11
Day Low/High 3.09 / 3.32
52 Wk Low/High 1.56 / 4.14
Volume 1.05M
Avg Volume 832.80K
Exchange NASDAQ
Shares Outstanding 703.09M
Market Cap 2.11B
EPS -0.50
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

BioScrip Announces Shareholder Approval Of Merger With Option Care

BioScrip Announces Shareholder Approval Of Merger With Option Care

DENVER, Aug. 02, 2019 (GLOBE NEWSWIRE) -- BioScrip, Inc.

BioScrip Reports Second Quarter 2019 Financial Results

BioScrip Reports Second Quarter 2019 Financial Results

DENVER, July 30, 2019 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced its second quarter 2019 financial results.

URGENT ALERT: Monteverde & Associates PC Launches An Investigation Regarding The Following Merger

URGENT ALERT: Monteverde & Associates PC Launches An Investigation Regarding The Following Merger

NEW YORK, June 21, 2019 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating: BioScrip, Inc.

Bioservo Technologies Introduces The Next Version Of Ironhand® - The World's First Soft Robotic Muscle Strengthening System

Bioservo Technologies Introduces The Next Version Of Ironhand® - The World's First Soft Robotic Muscle Strengthening System

STOCKHOLM, May 7, 2019 /PRNewswire/ -- Bioservo Technologies AB (publ) (Nasdaq First North: BIOS) announced today that the company introduces the next version of Ironhand® that offers significant improvements for the user.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AEIS, CIZN, ISRL Downgrades: BIOS, MG, NOK, NWHM, RLH Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Infusion Therapy Firm BioScrip to Buy Rival Option Care

Infusion Therapy Firm BioScrip to Buy Rival Option Care

BioScrip agrees to buy rival Option Care Enterprises, creating one of the largest independent home-therapy companies in the U.S.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ALK, ARCO, BIOS, CRD.A, DCO, GNE, KEYW, LOGM, OUT, SIGA, TBBK, TGP, TPIC, XXII Downgrades: ADS, BYD, CCS, ENTA, HL, ICBK, MTW, XOMA Initiations: BPMP, PTGX Read on to get TheStreet Quant Ratings' detailed report:

BioScrip Provides Update On Annual Form 10-K Filing Status

BioScrip Provides Update On Annual Form 10-K Filing Status

BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that it will be filing a Form 12b-25 with the U.

BioScrip Reports Fourth Quarter And Full Year 2017 Financial Results

BioScrip Reports Fourth Quarter And Full Year 2017 Financial Results

BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced its preliminary 2017 financial results and provided...

BioScrip Schedules Release Of Fourth Quarter And Full Year 2017 Financial Results And Conference Call

BioScrip Schedules Release Of Fourth Quarter And Full Year 2017 Financial Results And Conference Call

BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that the Company will issue its financial results press...

BIOS: Insiders Vs. Shorts

BIOS: Insiders Vs. Shorts

The most recent short interest data was recently released for the 01/31/2018 settlement date, and BioScrip Inc is one of the most shorted stocks of the Russell 3000, based on 12.29 "days to cover" versus the median component at 4.26. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

BioScrip Announces U.S. Congress Passage Of Medicare Home Infusion Transition Benefit, Effective 2019

BioScrip Announces U.S. Congress Passage Of Medicare Home Infusion Transition Benefit, Effective 2019

BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that the U.

Commit To Buy BioScrip At $2.50, Earn 23.9% Annualized Using Options

Commit To Buy BioScrip At $2.50, Earn 23.9% Annualized Using Options

Investors considering a purchase of BioScrip Inc stock, but cautious about paying the going market price of $2.99/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the July put at the $2.50 strike, which has a bid at the time of this writing of 30 cents.

BioScrip Announces Additions To Senior Leadership Team

BioScrip Announces Additions To Senior Leadership Team

Appoints Harriet Booker as Senior Vice President, Chief Operating Officer and Danny R. Claycomb as Senior Vice President, Revenue Cycle Management

BIOS: Insiders vs. Shorts

BIOS: Insiders vs. Shorts

The most recent short interest data was recently released for the 10/31/2017 settlement date, and BioScrip Inc is one of the most shorted stocks of the Russell 3000, based on 18.82 "days to cover" versus the median component at 5.18. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

Short Interest Drops 11.6% For BIOS

Short Interest Drops 11.6% For BIOS

The most recent short interest data has been released for the 08/31/2017 settlement date, which shows a 2,458,477 share decrease in total short interest for BioScrip Inc , to 18,783,163, a decrease of 11.57% since 08/15/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.